Companion Diagnostics or Theransotics Products in the Market
Tue, February 14 2012, 12:00 AM Posted By: Sciclips
Following are some of the companion diagnostics or theranostics products that are currently available (may not be available worldwide), in addition to the US FDA approved Genetech's Hercept® with DakoCytomation's HercepTest® for breast cancer and Roche's Zelboraf ® and companion diagnostic test for late-stage skin cancer.
4. AtheroAbzymeTM ELISA (from Cambridge Theranostics) - this test is used for identifying the risk of developing diseases caused by the oxidation of lipids due to the presence of active ALOA (Atherogenic Lipid-Oxidising Antibodies). This test can also be used for monitoring patients who were treated with anti-ALOA.
5. CancerTYPE ID® (from bioTheranostics) - a molecular diagnostic test for the determination of tumor site of origin using differential expression of 92 genes.
6. Breast Cancer IndexSM- (from bioTheranostics) - a prognostic biomarker based test for the quantitative assessment of the likelihood of distant recurrence in estrogen receptor-positive, lymph node-negative breast cancer patients.
7. PRÉCISSM Precision Medicine (from bioTheranostics) - biomarker profiling based test for the detection of clinically relevant tumor biomarkers for non-small cell lung cancer (NSCLC) and colorectal cancer.